New Weight Loss Drug Retatrutide Delivers Stunning Results

Eli Lilly's new weight loss drug retatrutide has shown remarkable trial results, potentially outperforming existing GLP-1 medications. The drug works by mimicking three hormones that regulate hunger and fat burning. NBC medical contributor Dr. Natalie Azar discusses the trial outcomes and FDA approval timeline.